These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 23857016

  • 1. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
    Gola M, D'Erme AM, Milanesi N, Marmugi L.
    Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
    [Abstract] [Full Text] [Related]

  • 2. Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study.
    Augustin M, Thaçi D, Kamps A.
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1261-1270. PubMed ID: 27992140
    [Abstract] [Full Text] [Related]

  • 3. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M.
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [Abstract] [Full Text] [Related]

  • 4. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF, Graff O, Hamedani AG.
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Holló P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J.
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
    English J, Graham-Brown R, de Sica Chapman A, Alexandroff AB.
    Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.
    Thaçi D, Augustin M, Westermayer B, Kamps A, Hennig M.
    J Dermatolog Treat; 2016 Nov; 27(6):577-583. PubMed ID: 27618281
    [Abstract] [Full Text] [Related]

  • 11. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.
    Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M.
    Pharmacoeconomics; 2010 Nov; 28(5):351-62. PubMed ID: 20131924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzicka T, Maares J, Brown TC.
    Br J Dermatol; 2010 Feb 01; 162(2):420-6. PubMed ID: 19906075
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
    Schmitt-Hoffmann AH, Roos B, Sauer J, Spickermann J, Stoeckel K, Edwards D, van de Wetering J, Coenraads PJ, Maares J.
    Clin Exp Dermatol; 2011 Apr 01; 36 Suppl 2():29-34. PubMed ID: 21443602
    [Abstract] [Full Text] [Related]

  • 15. [Off-label use of alitretinoin].
    Fritz K, Tiplica GS, Salavastru C, Onder M.
    Hautarzt; 2013 Oct 01; 64(10):748-51. PubMed ID: 24150823
    [Abstract] [Full Text] [Related]

  • 16. Comparative Study of Efficacy Between Cyclosporine and Alitretinoin in Patients With Chronic Hand Eczema.
    Jang JH, Joh HC, Song CH, Kim KY, Jue MS, Ro YS, Ko JY.
    Dermatitis; 2024 Oct 01; 35(3):258-265. PubMed ID: 37870578
    [Abstract] [Full Text] [Related]

  • 17. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
    Politiek K, Christoffers WA, Coenraads PJ, Schuttelaar MA.
    Dermatol Ther; 2016 Sep 01; 29(5):364-371. PubMed ID: 27146260
    [Abstract] [Full Text] [Related]

  • 18. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
    Molin S, Ruzicka T.
    Hautarzt; 2008 Sep 01; 59(9):703-4, 706-9. PubMed ID: 18704345
    [Abstract] [Full Text] [Related]

  • 19. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
    Kumari V, Timm K, Kühl AA, Heine G, Worm M.
    Br J Dermatol; 2016 Dec 01; 175(6):1243-1250. PubMed ID: 27480504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.